Table 1 Participant demographic and clinical characteristics.
Characteristic | Group; mean ± SD or no. (%) | Statistics | P value | |
|---|---|---|---|---|
Control (n = 325) | MPDs (n = 403) | |||
Demographic characteristics | ||||
Age, years | 29.24 (9.94) | 28.47 (8.88) | 1.091 | 0.27 |
Gender (male/female) | 132/193 | 143/260 | 2.015 | 0.156 |
Right handedness | 303 (93%) | 360 (89%) | 0.796 | 0.672 |
Weighta | 62.41 (14.39) | 62.90 (12.93) | −0.479 | 0.632 |
BMI (kg/m2)a | 23.76 (26.60) | 22.58 (3.90) | 0.857 | 0.392 |
Smoking | 37/188 (20%) | 49/206 (24%) | 0.971 | 0.324 |
Clinical characteristics | ||||
First episode, yes | – | 262 (65%) | – | – |
Medication, yes | – | 259 (64%) | – | – |
Antidepressant | – | 125 (31%) | ||
Mood stabiliser | – | 70 (17%) | – | – |
Antipsychotic | – | 124 (31%) | – | – |
Duration, months | – | 32.98 (49.21) | – | – |
HAMDb | 1.27 (2.16) | 13.79 (10.57) | −20.262 | <0.001 |
YMRSc | 0.25 (0.93) | 2.97 (6.40) | −7.255 | <0.001 |
BPRSd | 18.42 (1.94) | 28.90 (10.08) | −15.779 | <0.001 |
Leptin (pg/ml)e | 5463.13 (4055.93) | 9510.14 (9539.14) | −4.011 | <0.001 |
Leptin (log)e | 3.57 (0.44) | 3.78 (0.46) | −3.104 | 0.002 |